Pharmaceutical Sciences
Global

Pharmaceutical Sciences Experts

Randall Whitcomb

Independent Director
Drug Development
Millendo Therapeutics
United States of America

Biography

 Dr. Randy Whitcomb has over 35 years of experience as an endocrinologist, chief medical officer, and drug development executive. He is a Senior Advisor to Frazier Healthcare Partners' Life Sciences team and is closely involved with the sourcing and evaluation of new opportunities. He has been involved with a number of portfolio companies to assist with clinical trial design and execution, regulatory strategy, and other development-related activities. Previously, Dr. Whitcomb was a co-founder and Chief Medical Officer of QuatRx Pharmaceuticals, a pharmaceutical company focusing on compounds in the endocrine and metabolic therapeutic areas. Earlier he served in various management positions at Parke-Davis, the pharmaceutical division of Warner-Lambert, including VP for Clinical Research and Drug Development. After Pfizer acquired Warner-Lambert, Dr. Whitcomb was VP of Global Project Management for Pfizer. Throughout his time in the pharmaceutical industry, he has been involved in the development and approval of several drugs including: Lipitor, Rezulin, FemHRT, Estrostep, and Osphena. Prior to his tenure at Parke-Davis, Dr. Whitcomb was on the faculty of the Harvard Medical School and an attending physician at Massachusetts General Hospital. He previously served on the boards of Insmed, Inc. and Marcadia Biotech, Inc. Dr. Whitcomb received his M.D. from the University of Kansas, where he did clinical training in internal medicine and endocrinology followed by a research fellowship at N.I.H. He earned a B.A. in Biology and Chemistry from Tabor College. Randy has authored multiple scientific publications and is a member of numerous scientific and clinical organizations.

Research Interest

 Drug Development,Healthcare 

Global Experts from United States of America

Global Experts in Subject

Share This Profile